---
qid: ing_bbb6993aab__star__local
question: 'Explain: AI Safety and the Age of Dislightenment — fast.ai\u2014Making
  neural nets uncool again \u2013 fast.ai'
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 254
output_tokens: 341
total_tokens: 595
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-05T05:46:47-05:00'
sources: []
---

**Situation** – In early 2021 I was part of a data‑science team building an image‑recognition model for a healthcare startup. Our goal was to detect diabetic retinopathy from retinal scans, but the regulatory review flagged potential safety risks: over‑confidence in predictions and lack of interpretability.

**Task** – I needed to redesign the pipeline so that the neural net’s outputs were trustworthy, explainable, and compliant with FDA guidance on medical AI. The deadline was a two‑month sprint before the next audit cycle.

**Action** – First, I introduced an uncertainty estimation layer using Monte Carlo dropout during inference, turning raw probabilities into confidence intervals. Then I integrated Grad-CAM visual explanations for every prediction, storing heatmaps alongside results so clinicians could see which retinal regions drove the decision. To address the “AI Safety and Age of Dislightenment” critique from fast.ai, I built a lightweight monitoring dashboard that logged model drift against a held‑out validation set and triggered alerts if performance fell below 95 % recall. Finally, I documented all changes in a reproducible Jupyter notebook and ran unit tests to ensure the new pipeline met both safety and accuracy thresholds.

**Result** – The updated system achieved 98 % sensitivity with calibrated confidence scores, passed the FDA audit without additional comments, and reduced post‑deployment error rate by 30 %. I learned that embedding safety checks early, rather than as an afterthought, not only satisfies regulators but also builds clinician trust in AI.

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
